| 摘要 |
PROBLEM TO BE SOLVED: To obtain a therapeutic agent for schizophrenia, effective against every schizophrenia in adolescence, and hardly causing side effects by including an adenosine phosphate ester (salt) as an active ingredient. SOLUTION: The objective therapeutic agent contains an adenosine phosphate ester (salt) as an active ingredient. Adenosine monophosphate, adenosine diphosphate and adenosine triphosphate are cited as the adenosine phosphate ester. The salt thereof is preferably an alkali metal salt, especially a sodium salt. A tablet, a granule, an enteric tablet or the like is cited as the form of the therapeutic agent. An oral medicine in an amount of a daily dose of 30-720 mg is preferably administered by dividing the dose into 1-3 times. Preferably an injection medicine in 5-100 mg per dose is intravenously injected once or twice a day, or the one in 20-160 mg per dose is injected y intravenous drip. In the case of intramuscular administration and subcutaneous administration, 5-100 mg per dose of the therapeutic agent is administered once or twice a day.
|
